XML 31 R11.htm IDEA: XBRL DOCUMENT v3.19.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Feb. 01, 2019
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS

The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of February 1, 2019 and February 2, 2018:
 
February 1, 2019 (a)
 
February 2, 2018 (a)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Quoted
Prices
in Active
Markets for
Identical
Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
 
 
Quoted
Prices
in Active
Markets for
Identical
Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
 
 
 
(in millions)
Assets:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Cash and cash equivalents:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
$
5,221

 
$

 
$

 
$
5,221

 
$
8,641

 
$

 
$

 
$
8,641

U.S. corporate debt securities

 

 

 

 

 
23

 

 
23

Foreign corporate debt securities

 

 

 

 

 
65

 

 
65

Debt securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government and agencies

 

 

 

 
682

 
392

 

 
1,074

U.S. corporate

 

 

 

 

 
2,003

 

 
2,003

Foreign

 

 

 

 

 
2,547

 

 
2,547

Equity and other securities
314

 
20

 

 
334

 
236

 
5

 

 
241

Derivative instruments

 
97

 

 
97

 

 
83

 

 
83

Total assets
$
5,535

 
$
117

 
$

 
$
5,652

 
$
9,559

 
$
5,118

 
$

 
$
14,677

Liabilities:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Derivative instruments
$

 
$
60

 
$

 
$
60

 
$

 
$
184

 
$

 
$
184

Total liabilities
$

 
$
60

 
$

 
$
60

 
$

 
$
184

 
$

 
$
184

____________________
(a)
The Company did not transfer any financial instruments between levels during the fiscal years ended February 1, 2019 and February 2, 2018.

The following section describes the valuation methodologies the Company uses to measure financial instruments at fair value:

Money Market Funds — The Company’s investment in money market funds that are classified as cash equivalents hold underlying investments with a weighted average maturity of 90 days or less and are recognized at fair value. The valuations of these securities are based on quoted prices in active markets for identical assets, when available, or pricing models whereby all significant inputs are observable or can be derived from or corroborated by observable market data. The Company reviews security pricing and assesses liquidity on a quarterly basis. As of February 1, 2019, the Company’s U.S. portfolio had no material exposure to money market funds with a fluctuating net asset value.

Equity and Other Securities — The majority of the Company’s investments in equity and other securities that are measured at fair value on a recurring basis consist of strategic investments in publicly-traded companies. The valuation of these securities is based on quoted prices in active markets.

Debt Securities — The majority of the Company’s debt securities consists of various fixed income securities such as U.S. government and agencies, U.S. corporate, and foreign. Valuation is based on pricing models whereby all significant inputs, including benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers, and other market related data, are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset. Inputs are documented in accordance with the fair value measurements hierarchy. The Company reviews security pricing and assesses liquidity on a quarterly basis. See Note 4 of the Notes to the Consolidated Financial Statements for additional information about investments.

Derivative Instruments — The Company’s derivative financial instruments consist primarily of foreign currency forward and purchased option contracts and interest rate swaps. The fair value of the portfolio is determined using valuation models based on market observable inputs, including interest rate curves, forward and spot prices for currencies, and implied volatilities. Credit risk is also factored into the fair value calculation of the Company’s derivative instrument portfolio. See Note 7 of the Notes to the Consolidated Financial Statements for a description of the Company’s derivative financial instrument activities.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis — Certain assets are measured at fair value on a nonrecurring basis and therefore are not included in the recurring fair value table above. These assets consist primarily of non-financial assets such as goodwill and intangible assets. See Note 8 of the Notes to the Consolidated Financial Statements for additional information about goodwill and intangible assets.

As of February 1, 2019 and February 2, 2018, the Company held private strategic investments of $671 million and $485 million, respectively. As these investments represent early-stage companies without readily determinable fair values, they are not included in the recurring fair value table above.

The Company has elected to apply the measurement alternative for these investments. Under the alternative, the Company measures investments without readily determinable fair values at cost, less impairment, adjusted by observable price changes. The Company must make a separate election to use the alternative for each eligible investment and is required to reassess at each reporting period whether an investment qualifies for the alternative. In evaluating these investments for impairment or observable price changes, the Company uses inputs including pre- and post-money valuations of recent financing events and the impact of those on its fully diluted ownership percentages, as well as other available information regarding the issuer’s historical and forecasted performance.

Carrying Value and Estimated Fair Value of Outstanding Debt — The following table summarizes the carrying value and estimated fair value of the Company’s outstanding debt as described in Note 6 of the Notes to the Consolidated Financial Statements, including the current portion, as of the dates indicated:
 
February 1, 2019
 
February 2, 2018
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
 
(in billions)
Senior Secured Credit Facilities
$
12.5

 
$
12.6

 
$
10.4

 
$
10.6

First Lien Notes
$
19.8

 
$
21.0

 
$
19.7

 
$
21.9

Unsecured Notes and Debentures
$
1.8

 
$
1.9

 
$
2.3

 
$
2.5

Senior Notes
$
3.1

 
$
3.4

 
$
3.1

 
$
3.4

EMC Notes
$
3.0

 
$
2.9

 
$
5.5

 
$
5.4

VMware Notes
$
4.0

 
$
3.9

 
$
4.0

 
$
3.9

Margin Loan Facility
$
3.3

 
$
3.4

 
$
2.0

 
$
2.0



The fair values of the outstanding debt shown in the table above, as well as the DFS debt described in Note 5 of the Notes to the Consolidated Financial Statements, were determined based on observable market prices in a less active market or based on valuation methodologies using observable inputs and were categorized as Level 2 in the fair value hierarchy. The carrying value of DFS debt approximates fair value.